[go: up one dir, main page]

FR2884423B1 - Utilisation de la lecithine comme medicament dans le traitement du psoriasis - Google Patents

Utilisation de la lecithine comme medicament dans le traitement du psoriasis

Info

Publication number
FR2884423B1
FR2884423B1 FR0506496A FR0506496A FR2884423B1 FR 2884423 B1 FR2884423 B1 FR 2884423B1 FR 0506496 A FR0506496 A FR 0506496A FR 0506496 A FR0506496 A FR 0506496A FR 2884423 B1 FR2884423 B1 FR 2884423B1
Authority
FR
France
Prior art keywords
lecithin
psoriasis
treatment
medicinal product
marine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0506496A
Other languages
English (en)
Other versions
FR2884423A1 (fr
Inventor
Paul Dupont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DICOPHAR SOC CIV ILE
Original Assignee
DICOPHAR SOC CIV ILE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0506496A priority Critical patent/FR2884423B1/fr
Application filed by DICOPHAR SOC CIV ILE filed Critical DICOPHAR SOC CIV ILE
Priority to CA2606255A priority patent/CA2606255C/fr
Priority to PL06743672T priority patent/PL1871399T3/pl
Priority to PCT/FR2006/000792 priority patent/WO2006111633A2/fr
Priority to US11/911,743 priority patent/US7759325B2/en
Priority to EP06743672A priority patent/EP1871399B1/fr
Priority to AT06743672T priority patent/ATE496628T1/de
Priority to DE602006019842T priority patent/DE602006019842D1/de
Publication of FR2884423A1 publication Critical patent/FR2884423A1/fr
Application granted granted Critical
Publication of FR2884423B1 publication Critical patent/FR2884423B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0506496A 2005-04-18 2005-06-27 Utilisation de la lecithine comme medicament dans le traitement du psoriasis Expired - Fee Related FR2884423B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0506496A FR2884423B1 (fr) 2005-04-18 2005-06-27 Utilisation de la lecithine comme medicament dans le traitement du psoriasis
PL06743672T PL1871399T3 (pl) 2005-04-18 2006-04-11 Zastosowanie lecytyny jako leku w leczeniu łuszczycy
PCT/FR2006/000792 WO2006111633A2 (fr) 2005-04-18 2006-04-11 Utilisation de la lecithine comme medicament dans le traitement du psoriasis
US11/911,743 US7759325B2 (en) 2005-04-18 2006-04-11 Use of lecithin as a medication for the treatment of psoriasis
CA2606255A CA2606255C (fr) 2005-04-18 2006-04-11 Utilisation de la lecithine comme medicament dans le traitement du psoriasis
EP06743672A EP1871399B1 (fr) 2005-04-18 2006-04-11 Utilisation de la lecithine comme medicament dans le traitement du psoriasis
AT06743672T ATE496628T1 (de) 2005-04-18 2006-04-11 Verwendung von lecithin als arzneimittel zur behandlung von psoriasis
DE602006019842T DE602006019842D1 (de) 2005-04-18 2006-04-11 Verwendung von lecithin als arzneimittel zur behandlung von psoriasis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503827A FR2884425B3 (fr) 2005-04-18 2005-04-18 Composition pharmaceutique destinee a soigner le psoriasis
FR0506496A FR2884423B1 (fr) 2005-04-18 2005-06-27 Utilisation de la lecithine comme medicament dans le traitement du psoriasis

Publications (2)

Publication Number Publication Date
FR2884423A1 FR2884423A1 (fr) 2006-10-20
FR2884423B1 true FR2884423B1 (fr) 2007-06-22

Family

ID=35463696

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0503827A Expired - Lifetime FR2884425B3 (fr) 2005-04-18 2005-04-18 Composition pharmaceutique destinee a soigner le psoriasis
FR0506496A Expired - Fee Related FR2884423B1 (fr) 2005-04-18 2005-06-27 Utilisation de la lecithine comme medicament dans le traitement du psoriasis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR0503827A Expired - Lifetime FR2884425B3 (fr) 2005-04-18 2005-04-18 Composition pharmaceutique destinee a soigner le psoriasis

Country Status (4)

Country Link
AT (1) ATE496628T1 (fr)
DE (1) DE602006019842D1 (fr)
ES (1) ES2359987T3 (fr)
FR (2) FR2884425B3 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108004016A (zh) * 2017-12-18 2018-05-08 青岛康境海洋生物科技有限公司 一种高卵磷脂含量的南极磷虾油的制备方法
CN113995763B (zh) * 2021-11-10 2023-08-11 中南大学湘雅医院 磷脂酰乙醇胺作为活性成分在制备银屑病治疗药物中的应用、银屑病治疗药物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042348A1 (fr) * 1997-03-25 1998-10-01 Wilson Trafton Crandall Composition hydratante topique et methode associee
US20020012648A1 (en) * 1998-02-06 2002-01-31 Orthoefer Frank T. High phospholipid-containing dermatological compositions
WO2005002591A1 (fr) * 2003-07-02 2005-01-13 Fouad Abdelaziz Ahmed Hassanin Traitement du psoriasis, de l'impetigo, de la teigne par lipositol, cephaline et lecithine

Also Published As

Publication number Publication date
ES2359987T3 (es) 2011-05-30
FR2884425A1 (fr) 2006-10-20
FR2884423A1 (fr) 2006-10-20
FR2884425B3 (fr) 2007-05-25
DE602006019842D1 (de) 2011-03-10
ATE496628T1 (de) 2011-02-15

Similar Documents

Publication Publication Date Title
Matei et al. Applications of nanosized-lipid-based drug delivery systems in wound care
EA201300213A1 (ru) Применение ингибиторов dpp iv
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
BR112012029959A2 (pt) compostos de carbamato de mentila como ativos para clareamento de pele e/ou cabelo
ATE525084T1 (de) Verwendung von mindestens einem botulinum- neurotoxin zur behandlung von schmerzen infolge therapeutischer behandlungen für das aids-virus
EA200702204A1 (ru) Лечение заболеваний соединительной ткани кожи
WO2004100893A3 (fr) Methodes de traitement d'affections inflammatoires a l'aide de ct-3 ou de ses analogues
UY28209A1 (es) Derivados de aminoácidos con cicloalquilo, procedimiento para su preparación y su uso como medicamentos.
RU2007101538A (ru) Применение фармацевтической композиции, содержащей кальцитриол и пропионат клобетазола, для лечения псориаза
BRPI0507622B8 (pt) composto baseado em ácido hialurônico, processo para preparar um composto ou um sal do mesmo, composição farmacêutica, produto medicinal e dispositivo médico para uso humano ou veterinário, e,uso de composto ou de um sal do mesmo
FR2936149B1 (fr) Utilisation de l'alverine dans le traitement des affections cutanees
NO20075199L (no) Treatment or prevention of pruritus
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
FR2884423B1 (fr) Utilisation de la lecithine comme medicament dans le traitement du psoriasis
DK2004235T3 (da) Sammensætning til kosmetisk eller farmaceutisk-dermatologisk anvendelse
PT1585513E (pt) Utilizacao de acido docosa-hexaenoico como substancia activa para o tratamento de lipodistrofia
TW200716192A (en) Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases
WO2006076119A3 (fr) Traitement de dermatoses
MA28210A1 (fr) Composition pharmaceutique contenant en association l'ubidecarenone, le dexpanthenol et le chlorhexidine ou leurs sels acceptables du point de vue pharmaceutique pour application cutanee
HUP0600046A2 (en) Pharmaceutical composition containing folic acid and it's use
TH87784B (th) สูตรเฉพาะที่มี o-เดสเมทธิลเวนลาฟาซีน(odv)หรือเกลือของมัน
TNSN06068A1 (en) Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application
BRPI0404771A (pt) medicamento e tratamento para dores em geral e outros sintomas
UA87052C2 (ru) Мазь на основе тиотриазолина для лечения раневого процесса во второй и третьей стадиях
TH85829B (th) การบำบัดโรคที่เกี่ยวกับเนื้อเยื่อที่เชื่อมกันของผิวหนัง

Legal Events

Date Code Title Description
CL Concession to grant licences

Name of requester: PHYBIO PHARMA, CH

Effective date: 20130218

Name of requester: SARL PHYTOBIOLAB, FR

Effective date: 20130218

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20250205